Michael J Leveridge1,2, D Robert Siemens1,2, Jason P Izard1,2, Xuejiao Wei3, Christopher M Booth2,4,3. 1. Departments of Urology; Queen's University, Kingston, ON, Canada. 2. Oncology; Queen's University, Kingston, ON, Canada. 3. Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute; Queen's University, Kingston, ON, Canada. 4. Public Health Sciences; Queen's University, Kingston, ON, Canada.
Abstract
INTRODUCTION: Partial cystectomy (PC) for urothelial carcinoma (UC) in selected patients may avoid the morbidity of radical cystectomy (RC). We describe use and outcomes of PC for UC in routine clinical practice. METHODS: All patients with urothelial carcinoma of the bladder (UCB) undergoing PC or RC in Ontario from 1994-2008 were identified using the Ontario Cancer Registry and linked electronic records. Pathology reports were reviewed. Variables associated with PC use were identified using logistic regression. Cox proportional hazards model identified factors affecting cancer-specific (CSS) and overall survival (OS). RESULTS: A total of 3320 patients underwent PC (n=181; 5%) or RC (n=3139; 95%) from 1994-2008. PC patients were older (36% 80+ years vs. 19%; p<0.001) and more likely to have organ-confined (<pT3) disease (54% vs. 36% RC; p<0.001). Two-thirds (67%) of PC patients did not undergo lymph node dissection (24% for RC; p<0.001). Factors associated with having PC included older age (odds ratio [OR] 1.55; 95% confidence interval [CI] 0.96-2.51 for 70+ years), moderate comorbidity (OR 1.95; 95% CI 1.13-3.37), and surgery outside of a comprehensive cancer centre (OR 1.44; 95% CI 1.03-2.01). Unadjusted five-year OS for PC and RC cases was 34% and 33%, respectively (p=0.455); CSS at five years was 43% and 37% (p=0.045). On adjusted analysis, PC was associated with comparable CSS (hazard ratio [HR] 0.87, 95% CI 0.70-1.09) and OS (HR 0.95, 95% CI 0.79-1.14) as RC. CONCLUSIONS: In routine clinical practice, PC is not common. A substantial proportion of patients treated with PC achieve long-term survival. PC remains a treatment option in selected patients with UCB.
INTRODUCTION: Partial cystectomy (PC) for urothelial carcinoma (UC) in selected patients may avoid the morbidity of radical cystectomy (RC). We describe use and outcomes of PC for UC in routine clinical practice. METHODS: All patients with urothelial carcinoma of the bladder (UCB) undergoing PC or RC in Ontario from 1994-2008 were identified using the Ontario Cancer Registry and linked electronic records. Pathology reports were reviewed. Variables associated with PC use were identified using logistic regression. Cox proportional hazards model identified factors affecting cancer-specific (CSS) and overall survival (OS). RESULTS: A total of 3320 patients underwent PC (n=181; 5%) or RC (n=3139; 95%) from 1994-2008. PCpatients were older (36% 80+ years vs. 19%; p<0.001) and more likely to have organ-confined (<pT3) disease (54% vs. 36% RC; p<0.001). Two-thirds (67%) of PCpatients did not undergo lymph node dissection (24% for RC; p<0.001). Factors associated with having PC included older age (odds ratio [OR] 1.55; 95% confidence interval [CI] 0.96-2.51 for 70+ years), moderate comorbidity (OR 1.95; 95% CI 1.13-3.37), and surgery outside of a comprehensive cancer centre (OR 1.44; 95% CI 1.03-2.01). Unadjusted five-year OS for PC and RC cases was 34% and 33%, respectively (p=0.455); CSS at five years was 43% and 37% (p=0.045). On adjusted analysis, PC was associated with comparable CSS (hazard ratio [HR] 0.87, 95% CI 0.70-1.09) and OS (HR 0.95, 95% CI 0.79-1.14) as RC. CONCLUSIONS: In routine clinical practice, PC is not common. A substantial proportion of patients treated with PC achieve long-term survival. PC remains a treatment option in selected patients with UCB.
Authors: Michael J Leveridge; D Robert Siemens; William J Mackillop; Yingwei Peng; Ian F Tannock; David M Berman; Christopher M Booth Journal: Urology Date: 2015-02-07 Impact factor: 2.649
Authors: Atreya Dash; Matthew D Galsky; Andrew J Vickers; Angel M Serio; Theresa M Koppie; Guido Dalbagni; Bernard H Bochner Journal: Cancer Date: 2006-08-01 Impact factor: 6.860
Authors: Wassim Kassouf; David Swanson; Ashish M Kamat; Dan Leibovici; Arlene Siefker-Radtke; Mark F Munsell; H Barton Grossman; Colin P N Dinney Journal: J Urol Date: 2006-06 Impact factor: 7.450
Authors: Ugo Fedeli; Giacomo Novara; Claudia Galassi; Vincenzo Ficarra; Elena Schievano; Marco Gilardetti; Giovanni Muto; Oscar Bertetto; Giovannino Ciccone; Paolo Spolaore Journal: BJU Int Date: 2011-02-14 Impact factor: 5.588
Authors: Nicholas D James; Syed A Hussain; Emma Hall; Peter Jenkins; Jean Tremlett; Christine Rawlings; Malcolm Crundwell; Bruce Sizer; Thiagarajan Sreenivasan; Carey Hendron; Rebecca Lewis; Rachel Waters; Robert A Huddart Journal: N Engl J Med Date: 2012-04-19 Impact factor: 91.245
Authors: Jeffrey M Holzbeierlein; Ernesto Lopez-Corona; Bernard H Bochner; Harry W Herr; S Machele Donat; Paul Russo; Guido Dalbagni; Pramod C Sogani Journal: J Urol Date: 2004-09 Impact factor: 7.450
Authors: Umberto Capitanio; Hendrik Isbarn; Shahrokh F Shariat; Claudio Jeldres; Laurent Zini; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz Journal: Urology Date: 2009-07-22 Impact factor: 2.649